Bristol arthritis drug effective in children: study
14th Nov 2006, 00:27 GMT
NEW YORK (Reuters) - Bristol-Myers Squibb Co.'s new rheumatoid arthritis drug Orencia, which is approved for adult use, appeared to be effective in treating children as well, according to a study released on Monday.
Bristol arthritis drug effective in children: study related news:
- Bristol arthritis drug effective in children: study (Reuters) — Yahoo! Health: Health News
- Adalimumab Proves Effective For Children With Juvenile Rheumatoid Arthritis — Health News from Medical News Today
- ORENCIA(R) (abatacept) Data Demonstrated Improvement In Children And Adolescents With Juvenile Idiopathic Arthritis — Health News from Medical News Today
- Abbott's Humira Positive in 2 Studies — Operations-Related News from StratCenter.com
- Scots go-ahead for arthritis drug — Scotsman.com News
- Isis Says New Drug Effective Against Cholesterol — RedOrbit News - Health
- Merck: New pain drug safer than Vioxx — Financial news of the day - CNNMoney.com
- Merck: New drug safer than Vioxx — Business and financial news - CNNMoney.com
- Turmeric prevents rheumatoid arthritis: US study — NewKerala Health News
- Anti-TNF Golimumab (CNTO 148) Continues To Show Promise In Phase 2 Rheumatoid Arthritis Study — Health News from Medical News Today
Latest news from Reuters: Health:
- Roche flu drug to carry new caution in U.S.
- Gene chip test identifies bird flu strains
- World's poor still deprived of drugs: activists
- Study questions radiation after prostate removal
- Chocolate addiction leads to sweet discovery
- Researchers spur growth of adult brain stem cells
- Angioplasty no help for heart attack victims who wait
- Diabetics fare better with drug-eluting stents
- Very obese fare worse after colon cancer diagnosis
- Companies vow to rein in kid junk food ads